Clinical trial Recruiting at 8 sites Interventional Ages 18 and up

Evaluating a new surgical irrigation method for joint replacement surgeries

Official title: Evaluating XPERIENCE™ Advanced Surgical Irrigation on Risk of Periprosthetic Joint Infection: A Multicenter Randomized Controlled Trial

Run by Ottawa Hospital Research Institute · NCT05543941 · Data updated 2026-11-12

This study is testing a new way to clean the surgical area during knee or hip replacement surgeries to see if it can lower the risk of infections compared to the usual method.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment7600 (estimated)
SponsorOttawa Hospital Research Institute
Academic / other
Drugs / interventionsprednisone
Locations8 sites (Vancouver, British Columbia and 7 other locations)
StatusRecruiting
StartedApril 1, 2023
Main results expectedMarch 31, 2027
Study endsDecember 31, 2027
Registry record updatedMay 28, 2026
Trial IDNCT05543941 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older with osteoarthritis or other specified joint conditions who are scheduled for total knee or hip arthroplasty.

Probably not a fit

Patients who have had prior surgeries on the affected joint or have specific allergies or infections may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial is designed to compare the effectiveness of XPERIENCE™ Advanced Surgical Irrigation against dilute Betadine in preventing periprosthetic joint infections in patients undergoing total knee or hip arthroplasty. It is a prospective, multi-center, double-arm, parallel, interventional, randomized, controlled trial. Participants will be randomly assigned to receive either the new irrigation method or the standard treatment during their surgery. The study aims to gather data on infection rates post-surgery to determine if the new method offers significant advantages.

Why it matters

Potential benefit: If successful, this study could lead to a reduction in joint infections following major orthopedic surgeries, improving patient outcomes.

How similar studies have gone: Other studies have explored various irrigation methods in surgical settings, but the specific use of XPERIENCE™ Advanced Surgical Irrigation in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Male and female patients aged 18 years or older
2. Diagnosis of osteoarthritis, inflammatory arthritis, osteonecrosis, or post-traumatic arthritis to the affected joint.
3. Primary TKA, THA, and HR
4. Subjects receiving both cemented or uncemented orthopaedic implants
5. Willing and able to sign written consent, follow study protocol and attend follow-up

Exclusion Criteria:

1. Inability or refusal to sign informed consent form
2. Non-English or French speaking, and no licensed translator, family member or substitute decision maker available.
3. Prior arthroplasty procedure to the affected joint
4. Procedures involving solid HA implants
5. Oncologic diagnosis to the affected joint.
6. Non-TKA, THA or HR prosthesis (i.e., hemiarthroplasty, unicompartmental arthroplasty etc.)
7. Allergy to any of the components of XP Advanced Surgical Irrigation
8. Allergy to iodine
9. Presence of concurrent active infection, primary immunodeficiency, history of uncontrolled HIV (CD4 count \<200 cells/uL), treatment with immunomodulatory medications for malignancy or autoimmune disease (with exception to inflammatory arthritis), chronic glucocorticosteroid use (≥20 mg of prednisone daily for at least 1 month with another cause of immunosuppression), and solid organ and/or bone marrow transplantation.
10. History of septic arthritis to the affected joint within two years of surgery(1).
11. History of steroid injection to the affected joint within the three months preceding surgery.
12. Simultaneous bilateral total joint arthroplasty

Where it's running

  • University of British Columbia
    Vancouver, British Columbia, Canada
    Recruiting
  • London Health Sciences Center
    London, Ontario, Canada
    Recruiting
  • The Ottawa Hospital
    Ottawa, Ontario, Canada
    Recruiting
  • Humber River Health
    Toronto, Ontario, Canada
    Recruiting
  • St. Joseph's Health Centre
    Toronto, Ontario, Canada
    Recruiting
  • Hôpital Maisonneuve-Rosemont
    Montreal, Quebec, Canada
    Recruiting
Show 2 more locations
  • Jewish General Hospital
    Montreal, Quebec, Canada
    Recruiting
  • CHU de Quebec-Université Laval
    Québec, Quebec, Canada
    Recruiting

Study contacts

  • Principal investigator: Simon Garceau, MD — The Ottawa Hospital
  • Study coordinator: Sanjula Costa
  • Email: scosta@ohri.ca
  • Phone: 613-737-8899

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.